首页 › 基金 › Foresite Capital Management VI LLC › ANIX

Foresite Capital Management VI LLC 对 ANIX 的持仓历史

ANIXA BIOSCIENCES INC · 医疗保健

Foresite Capital Management VI LLC 在 Q3 2026 的 13F 申报中披露持有 ANIX(ANIXA BIOSCIENCES INC)1,431,660 股,市值约 US$45.8M,约占其申报组合的 8.09%,在其申报持仓中市值排名第 2 位。 Foresite Capital Management VI LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)1.43M 股
申报持仓市值$45.81M
组合权重8.09%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Foresite Capital Management VI LLC 对 ANIX 的持仓演变

Foresite Capital Management VI LLC 于 Q3 2026 首次披露 ANIX 持仓:1,431,660 股(约 US$45.8M)。

逐季持仓明细

季度股数金额变化
Q3 2026 1.43M $45.81M 新进

关于 ANIX 与 13F 数据

ANIX(ANIXA BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 55 只申报持有 ANIX,申报仓位最大的包括:Fairmount Funds Management LLC (US$291.3M), TCG Crossover Management, LLC (US$145.6M), Venrock Adviser, LLC (US$145.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ANIX 的基金

查看 ANIX 的全部基金持有人 →

常见问题

How long has Foresite Capital Management VI LLC held ANIX?

Foresite Capital Management VI LLC has disclosed ANIX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Foresite Capital Management VI LLC's current position in ANIX?

As of Q3 2026, Foresite Capital Management VI LLC holds 1.43M shares of ANIX (ANIXA BIOSCIENCES INC), valued at $45.81M, representing 8.09% of its reported portfolio and ranking #2.

Has Foresite Capital Management VI LLC been buying or selling ANIX?

In the latest 13F filing (Q3 2026), Foresite Capital Management VI LLC newly opened its position in ANIX.

Which other funds hold ANIX?

Other major institutional holders of ANIX include Fairmount Funds Management LLC, TCG Crossover Management, LLC, Venrock Adviser, LLC, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.